Clinical Trial Update: Novel mGluR5 Modulator Effects on Alcohol Drinking and MRI Outcomes [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating a novel mGluR5 modulator for alcohol use disorder, assessing its effects on alcohol consumption and MRI outcomes; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder

Drugs mentioned

• Novel mGluR5 modulator

Snippet

Sponsor: Medical University of South Carolina | Conditions: Alcohol Use Disorder | Phase 1, Phase 2 | Status: COMPLETED